News & AnalysisSynthace lands $35m Series CSynthace, a life sciences software company, has raised $35 million in Series C funding.ByIris Dorbian16 November 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsTechnologyBriefs